A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control
Authors:
- Fatéméh DuboisFDFatéméh Dubois
- Bastien Jean-JacquesBJBastien Jean-Jacques
- Hélène RobergeHRHélène Roberge
- Magalie BénardMBMagalie Bénard
- Ludovic GalasLGLudovic Galas
- Damien SchapmanDSDamien Schapman
- Nicolas ElieNENicolas Elie
- Didier GouxDGDidier Goux
- Maureen KellerMKMaureen Keller
- Elodie MailleEMElodie Maille
- Emmanuel BergotEBEmmanuel Bergot
- Gérard ZalcmanGZGérard Zalcman
Open Access
- 11 October 2018
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 16 (1) , 1-20
Abstract
By allowing intercellular communication between cells, tunneling nanotubes (TNTs) could play critical role in cancer progression. If TNT formation is known to require cytoskeleton remodeling, key mechanism controlling their formation remains poorly understood. The cells of human bronchial (HBEC-3, A549) or mesothelial (H2452, H28) lines are transfected with different siRNAs (inactive, anti-RASSF1A, anti-GEFH1 and / or anti-Rab11). At 48 h post-transfection, i) the number and length of the nanotubes per cell are quantified, ii) the organelles, previously labeled with specific tracers, exchanged via these structures are monitored in real time between cells cultured in 2D or 3D and in normoxia, hypoxia or in serum deprivation condition. We report that RASSF1A, a key-regulator of cytoskeleton encoded by a tumor-suppressor gene on 3p chromosome, is involved in TNTs formation in bronchial and pleural cells since controlling proper activity of RhoB guanine nucleotide exchange factor, GEF-H1. Indeed, the GEF-H1 inactivation induced by RASSF1A silencing, leads to Rab11 accumulation and subsequent exosome releasing, which in turn contribute to TNTs formation. Finally, we provide evidence involving TNT formation in bronchial carcinogenesis, by reporting that hypoxia or nutriment privation, two almost universal conditions in human cancers, fail to prevent TNTs induced by the oncogenic RASSF1A loss of expression. This finding suggests for the first time that loss of RASSF1A expression could be a potential biomarker for TNTs formation, such TNTs facilitating intercellular communication favoring multistep progression of bronchial epithelial cells toward overt malignancy.Keywords
Funding Information
- Ligue Contre le Cancer (2016)
This publication has 86 references indexed in Scilit:
- Cofilin Regulates Nuclear Architecture through a Myosin-II Dependent Mechanotransduction ModuleScientific Reports, 2017
- RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non–Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB PathwayCancer Research, 2016
- Tumor-Derived Exosomes and Their Role in Cancer Progression2016
- Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stressJournal of Extracellular Vesicles, 2013
- Tunneling NanotubesCommunicative & Integrative Biology, 2012
- LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formationJournal of Cell Science, 2012
- Imaging Cells in Three‐Dimensional Collagen MatrixCurrent Protocols in Cell Biology, 2010
- The RASSF1A tumor suppressorJournal of Cell Science, 2007
- Molecular requirements for epithelial–mesenchymal transition during tumor progressionCurrent Opinion in Cell Biology, 2005
- A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1)Trends in Pharmacological Sciences, 2005